Related Experiment Videos
Using chlamydia positivity to estimate prevalence: evidence from the Chlamydia Screening Pilot in England
D S LaMontagne1, K A Fenton, J M Pimenta
1Health Protection Agency, Communicable Disease Surveillance Centre, HIV and STI Department, 61 Colindale Avenue, London NW9 5EQ, UK. scott.lamontagne@hpa.org.uk
International Journal of STD & AIDS
|May 19, 2005
Summary
Positivity, calculated as total positive tests divided by total tests, can reliably estimate Chlamydia trachomatis prevalence in large-scale screening programs. This method proved accurate across different settings, age groups, and symptom statuses in a recent study.
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Control
Background:
- Chlamydia trachomatis screening programs are crucial for public health.
- Positivity has been suggested as a cost-effective proxy for estimating infection prevalence.
- Previous studies indicated potential utility, but continued validation is necessary.
Purpose of the Study:
- To assess the continued validity of using positivity as a proxy for Chlamydia trachomatis prevalence.
- To compare positivity estimates with actual prevalence data from a large-scale screening pilot.
Main Methods:
- Re-analysis of data from the Chlamydia Screening Pilot in England.
- Calculation of positivity as total positive tests divided by total tests.
- Comparison of positivity estimates with prevalence (positive tests divided by total screened).
Main Results:
- Positivity estimates in Portsmouth (9.4%) and Wirral (11.0%) closely matched reported prevalence (9.8% and 11.2%).
- No statistically significant differences were observed between positivity and prevalence.
- This accuracy was consistent across various health-care settings, age groups, and symptom presentations.
Conclusions:
- Positivity serves as a valid and reliable proxy for estimating Chlamydia trachomatis prevalence in screening programs.
- This finding supports the use of positivity for efficient large-scale epidemiological surveillance.
- The method's robustness across subgroups enhances its applicability in public health initiatives.